Cargando…
Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676526/ https://www.ncbi.nlm.nih.gov/pubmed/36419666 http://dx.doi.org/10.1016/j.heliyon.2022.e11558 |
| _version_ | 1784833616784654336 |
|---|---|
| author | Li, Ruxue Zhou, Wuai |
| author_facet | Li, Ruxue Zhou, Wuai |
| author_sort | Li, Ruxue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9676526 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96765262022-11-22 Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616] Li, Ruxue Zhou, Wuai Heliyon Corrigendum Elsevier 2022-11-13 /pmc/articles/PMC9676526/ /pubmed/36419666 http://dx.doi.org/10.1016/j.heliyon.2022.e11558 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Li, Ruxue Zhou, Wuai Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616] |
| title | Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616] |
| title_full | Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616] |
| title_fullStr | Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616] |
| title_full_unstemmed | Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616] |
| title_short | Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616] |
| title_sort | corrigendum to “multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [heliyon 8 (9), (september 2022) e09616] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676526/ https://www.ncbi.nlm.nih.gov/pubmed/36419666 http://dx.doi.org/10.1016/j.heliyon.2022.e11558 |
| work_keys_str_mv | AT liruxue corrigendumtomultiomicsanalysistoscreenpotentialtherapeuticbiomarkersforanticancercompoundsheliyon89september2022e09616 AT zhouwuai corrigendumtomultiomicsanalysistoscreenpotentialtherapeuticbiomarkersforanticancercompoundsheliyon89september2022e09616 |